晚期乳腺癌治疗反应的评估。
Assessment of response to therapy in advanced breast cancer.
作者信息
Hayward J L, Carbone P P, Heusen J C, Kumaoka S, Segaloff A, Rubens R D
出版信息
Br J Cancer. 1977 Mar;35(3):292-8. doi: 10.1038/bjc.1977.42.
Abstract
A system is proposed by the UICC for assessing response to treatment of advanced breast cancers.
摘要
国际抗癌联盟（UICC）提出了一种用于评估晚期乳腺癌治疗反应的系统。
相似文献
1
Assessment of response to therapy in advanced breast cancer.晚期乳腺癌治疗反应的评估。
Br J Cancer. 1977 Mar;35(3):292-8. doi: 10.1038/bjc.1977.42.
2
Management of locally advanced and disseminated breast cancer.局部晚期和转移性乳腺癌的管理
Lancet. 1981 Oct 10;2(8250):795-7. doi: 10.1016/s0140-6736(81)90198-7.
3
Adrenalectomy for advanced breast cancer: a reappraisal.晚期乳腺癌的肾上腺切除术：重新评估
Anticancer Res. 1983 Mar-Apr;3(2):151-3.
4
[Clinical studies on the treatment of advanced breast cancer with lung metastasis].[晚期乳腺癌肺转移治疗的临床研究]
Gan To Kagaku Ryoho. 1982 Jul;9(6):972-8.
5
High-dose chemotherapy plus hematopoietic stem-cell rescue for metastatic breast cancer.大剂量化疗联合造血干细胞救援治疗转移性乳腺癌。
N Engl J Med. 2000 Aug 10;343(6):439-40; author reply 440-1.
6
Pitfalls in outcome prediction of breast cancer.乳腺癌预后预测中的陷阱。
J Clin Pathol. 2013 Jun;66(6):458-64. doi: 10.1136/jclinpath-2012-201083. Epub 2013 Apr 25.
7
Definition and consequences of locally advanced breast cancer.局部晚期乳腺癌的定义和后果。
Curr Opin Support Palliat Care. 2014 Mar;8(1):33-8. doi: 10.1097/SPC.0000000000000020.
8
High-dose chemotherapy plus hematopoietic stem-cell rescue for metastatic breast cancer.大剂量化疗联合造血干细胞救援治疗转移性乳腺癌。
N Engl J Med. 2000 Aug 10;343(6):440; author reply 440-1.
9
High-dose chemotherapy plus hematopoietic stem-cell rescue for metastatic breast cancer.大剂量化疗联合造血干细胞救援治疗转移性乳腺癌。
N Engl J Med. 2000 Aug 10;343(6):439; author reply 440-1. doi: 10.1056/NEJM200008103430613.
10
[Treatment guideline for advanced or recurrent breast cancer].[晚期或复发性乳腺癌治疗指南]
Nihon Rinsho. 2000 Apr;58 Suppl:237-45.
引用本文的文献
1
Effect of neoadjuvant chemotherapy on CD14 + CD16 + monocytes and soluble CD163 in Egyptian breast cancer patients.新辅助化疗对埃及乳腺癌患者CD14+CD16+单核细胞及可溶性CD163的影响
Sci Rep. 2025 Feb 15;15(1):5676. doi: 10.1038/s41598-025-88719-5.
2
18F-fluorodeoxyglucose positron emission tomography-computed tomography in the localization of the lesions in the osteogenic region of breast cancer bone metastases after therapy.18F-氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描在乳腺癌骨转移灶治疗后成骨区域病变定位中的应用
Quant Imaging Med Surg. 2024 Jul 1;14(7):4950-4964. doi: 10.21037/qims-23-1738. Epub 2024 Jun 26.
3
Computed tomography density changes of bone metastases after concomitant denosumab.地舒单抗治疗后骨转移的 CT 密度变化
Skeletal Radiol. 2023 Aug;52(8):1567-1575. doi: 10.1007/s00256-023-04326-3. Epub 2023 Mar 24.
4
Breast MRI Tumor Automatic Segmentation and Triple-Negative Breast Cancer Discrimination Algorithm Based on Deep Learning.基于深度学习的乳腺 MRI 肿瘤自动分割与三阴性乳腺癌鉴别算法。
Comput Math Methods Med. 2022 Aug 31;2022:2541358. doi: 10.1155/2022/2541358. eCollection 2022.
5
DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival.新辅助化疗后 DNA 甲基化变化与乳腺癌生存相关。
Breast Cancer Res. 2022 Jun 24;24(1):43. doi: 10.1186/s13058-022-01537-9.
6
The impact of different volumetric thresholds to determine progressive disease in patients with recurrent glioblastoma treated with bevacizumab.不同体积阈值对接受贝伐单抗治疗的复发性胶质母细胞瘤患者确定疾病进展的影响。
Neurooncol Adv. 2022 Mar 9;4(1):vdac032. doi: 10.1093/noajnl/vdac032. eCollection 2022 Jan-Dec.
7
Patterns of biomarker expression in patients treated with primary endocrine therapy - a unique insight using core needle biopsy tissue microarray.接受原发性内分泌治疗的患者的生物标志物表达模式 - 使用核心针活检组织微阵列的独特见解。
Breast Cancer Res Treat. 2021 Feb;185(3):647-655. doi: 10.1007/s10549-020-06023-4. Epub 2020 Nov 23.
8
Bone metastases in thyroid cancer.甲状腺癌的骨转移
J Bone Oncol. 2020 Feb 19;21:100282. doi: 10.1016/j.jbo.2020.100282. eCollection 2020 Apr.
9
Silencing miR-150 Ameliorates Experimental Autoimmune Encephalomyelitis.沉默miR-150可改善实验性自身免疫性脑脊髓炎。
Front Neurosci. 2018 Jul 10;12:465. doi: 10.3389/fnins.2018.00465. eCollection 2018.
10
Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer.磷酸丝氨酸转氨酶 1 与复发性乳腺癌中他莫昔芬治疗的不良预后相关。
Sci Rep. 2017 May 18;7(1):2099. doi: 10.1038/s41598-017-02296-w.
Zotero 插件